Cardiac-specific hexokinase 2 overexpression attenuates hypertrophy by increasing pentose phosphate pathway flux. [electronic resource]
Producer: 20140616Description: e000355 p. digitalISSN:- 2047-9980
- Adrenergic alpha-Agonists -- pharmacology
- Animals
- Animals, Newborn
- Cardiomegaly -- chemically induced
- Cell Death
- Cells, Cultured
- Dehydroepiandrosterone -- pharmacology
- Disease Models, Animal
- Enzyme Inhibitors -- pharmacology
- Female
- Glucosephosphate Dehydrogenase -- antagonists & inhibitors
- Hexokinase -- genetics
- Isoproterenol
- Male
- Mice
- Mice, Transgenic
- Myocytes, Cardiac -- drug effects
- Oxidative Stress
- Pentose Phosphate Pathway -- drug effects
- Phenylephrine -- pharmacology
- RNA Interference
- Rats
- Rats, Sprague-Dawley
- Reactive Oxygen Species -- metabolism
- Time Factors
- Transfection
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.